BIONTECH SE

History

Year	Detail
2008	BioNTech was founded by Prof. Ugur Sahin, M.D., Prof. Özlem Türeci, M.D., and Prof. Christoph Huber, M.D., to change scientific discoveries into life-saving treatments.
2014	BioNTech initiated a first-in-human clinical trial utilizing an individualized mRNA cancer immunotherapy approach in solid tumors, designed to leverage BioNTech’s ML-trained algorithms.
2023	BioNTech acquired InstaDeep, a technology company specializing in the field of AI and machine learning, to further strengthen BioNTech’s position in AI-supported drug discovery, design and development.
2025	BioNTech acquired Biotheus to strengthen further BioNTech’s capabilities to develop, manufacture, and commercialize next-generation bispecific antibodies and novel treatment combinations.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment